(MSTR) MicroStrategy - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5949724083
Bitcoin Exposure, Analytics Software, Enterprise Intelligence
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 79.2% |
| Value at Risk 5%th | 120% |
| Relative Tail Risk | -7.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.70 |
| Alpha | -78.59 |
| CAGR/Max DD | 1.68 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.367 |
| Beta | 2.190 |
| Beta Downside | 1.336 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.02% |
| Mean DD | 19.58% |
| Median DD | 18.71% |
Description: MSTR MicroStrategy December 02, 2025
Strategy Inc. (formerly MicroStrategy) operates as a “bitcoin treasury company,” using its balance sheet to acquire and hold large quantities of Bitcoin while also issuing equity and fixed-income securities that give investors indirect exposure to the cryptocurrency’s price movements. In parallel, the firm sells AI-enabled enterprise analytics platforms-Strategy One for low-code insight delivery and Strategy Mosaic for unified data governance across heterogeneous sources.
Key data points (as of Q3 2024): the company’s Bitcoin holdings total roughly 150,000 BTC, representing over 30 % of its total assets; revenue from the analytics segment grew ~18 % YoY, driven by rising demand for generative-AI tools in the enterprise software market; and the firm’s free cash flow remains modest (~$50 M) because most cash is tied up in Bitcoin purchases, making the stock’s performance highly sensitive to Bitcoin price volatility. Sector-level drivers include accelerating AI adoption across industries and the broader trend of corporates using digital assets as a treasury hedge.
For a deeper quantitative assessment, consult ValueRay’s MSTR dashboard to explore the latest risk-adjusted metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (7.92b TTM) > 0 and > 6% of Revenue (6% = 28.5m TTM) |
| FCFTA -0.25 (>2.0%) and ΔFCFTA 38.41pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -23.19% (prev -21.84%; Δ -1.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.00 (>3.0%) and CFO -62.9m <= Net Income 7.92b (YES >=105%, WARN >=100%) |
| Net Debt (8.17b) to EBITDA (11.05b) ratio: 0.74 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (304.0m) change vs 12m ago 54.09% (target <= -2.0% for YES) |
| Gross Margin 70.12% (prev 73.56%; Δ -3.44pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.16% (prev 5.60%; Δ -4.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 78.71 (EBITDA TTM 11.05b / Interest Expense TTM 140.4m) >= 6 (WARN >= 3) |
Altman Z'' 3.92
| (A) -0.00 = (Total Current Assets 214.0m - Total Current Liabilities 324.1m) / Total Assets 73.62b |
| (B) 0.26 = Retained Earnings (Balance) 18.95b / Total Assets 73.62b |
| (C) 0.27 = EBIT TTM 11.05b / Avg Total Assets 40.98b |
| (D) 1.22 = Book Value of Equity 18.94b / Total Liabilities 15.50b |
| Total Rating: 3.92 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.29
| 1. Piotroski 4.0pt |
| 2. FCF Yield -30.93% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.14 |
| 5. Debt/Ebitda 0.74 |
| 6. ROIC - WACC (= 5.25)% |
| 7. RoE 19.76% |
| 8. Rev. Trend -49.41% |
| 9. EPS Trend 24.05% |
What is the price of MSTR shares?
As of December 02, 2025, the stock is trading at USD 171.42 with a total of 42,770,300 shares traded.
Over the past week, the price has changed by -4.26%, over one month by -35.23%, over three months by -49.82% and over the past year by -54.93%.
Over the past week, the price has changed by -4.26%, over one month by -35.23%, over three months by -49.82% and over the past year by -54.93%.
Is MSTR a buy, sell or hold?
MicroStrategy has received a consensus analysts rating of 4.31.
Therefore, it is recommended to buy MSTR.
- Strong Buy: 7
- Buy: 5
- Hold: 0
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the MSTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 517.2 | 201.7% |
| Analysts Target Price | 517.2 | 201.7% |
| ValueRay Target Price | 189 | 10.3% |
MSTR Fundamental Data Overview November 29, 2025
Market Cap USD = 50.47b (50.47b USD * 1.0 USD.USD)
P/E Trailing = 7.2102
P/E Forward = 2.9525
P/S = 106.2673
P/B = 0.9645
P/EG = 3.09
Beta = 3.374
Revenue TTM = 474.9m USD
EBIT TTM = 11.05b USD
EBITDA TTM = 11.05b USD
Long Term Debt = 8.17b USD (from longTermDebt, last quarter)
Short Term Debt = 316.0k USD (from shortTermDebt, last quarter)
Debt = 8.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.17b USD (from netDebt column, last quarter)
Enterprise Value = 58.64b USD (50.47b + Debt 8.22b - CCE 54.3m)
Interest Coverage Ratio = 78.71 (Ebit TTM 11.05b / Interest Expense TTM 140.4m)
FCF Yield = -30.93% (FCF TTM -18.14b / Enterprise Value 58.64b)
FCF Margin = -3819 % (FCF TTM -18.14b / Revenue TTM 474.9m)
Net Margin = 1667 % (Net Income TTM 7.92b / Revenue TTM 474.9m)
Gross Margin = 70.12% ((Revenue TTM 474.9m - Cost of Revenue TTM 141.9m) / Revenue TTM)
Gross Margin QoQ = 70.46% (prev 68.77%)
Tobins Q-Ratio = 0.80 (Enterprise Value 58.64b / Total Assets 73.62b)
Interest Expense / Debt = 1.08% (Interest Expense 88.9m / Debt 8.22b)
Taxrate = 28.06% (1.09b / 3.87b)
NOPAT = 7.95b (EBIT 11.05b * (1 - 28.06%))
Current Ratio = 0.66 (Total Current Assets 214.0m / Total Current Liabilities 324.1m)
Debt / Equity = 0.14 (Debt 8.22b / totalStockholderEquity, last quarter 58.12b)
Debt / EBITDA = 0.74 (Net Debt 8.17b / EBITDA 11.05b)
Debt / FCF = -0.45 (negative FCF - burning cash) (Net Debt 8.17b / FCF TTM -18.14b)
Total Stockholder Equity = 40.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.75% (Net Income 7.92b / Total Assets 73.62b)
RoE = 19.76% (Net Income TTM 7.92b / Total Stockholder Equity 40.06b)
RoCE = 22.91% (EBIT 11.05b / Capital Employed (Equity 40.06b + L.T.Debt 8.17b))
RoIC = 17.48% (NOPAT 7.95b / Invested Capital 45.48b)
WACC = 12.23% (E(50.47b)/V(58.69b) * Re(14.09%) + D(8.22b)/V(58.69b) * Rd(1.08%) * (1-Tc(0.28)))
Discount Rate = 14.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 28.62%
Fair Price DCF = unknown (Cash Flow -18.14b)
EPS Correlation: 24.05 | EPS CAGR: 13.02% | SUE: -2.51 | # QB: 0
Revenue Correlation: -49.41 | Revenue CAGR: -1.17% | SUE: 2.69 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.39 | Chg30d=+1.465 | Revisions Net=+0 | Analysts=4
EPS next Year (2026-12-31): EPS=32.73 | Chg30d=+21.937 | Revisions Net=+0 | Growth EPS=-33.4% | Growth Revenue=+2.4%
P/E Trailing = 7.2102
P/E Forward = 2.9525
P/S = 106.2673
P/B = 0.9645
P/EG = 3.09
Beta = 3.374
Revenue TTM = 474.9m USD
EBIT TTM = 11.05b USD
EBITDA TTM = 11.05b USD
Long Term Debt = 8.17b USD (from longTermDebt, last quarter)
Short Term Debt = 316.0k USD (from shortTermDebt, last quarter)
Debt = 8.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.17b USD (from netDebt column, last quarter)
Enterprise Value = 58.64b USD (50.47b + Debt 8.22b - CCE 54.3m)
Interest Coverage Ratio = 78.71 (Ebit TTM 11.05b / Interest Expense TTM 140.4m)
FCF Yield = -30.93% (FCF TTM -18.14b / Enterprise Value 58.64b)
FCF Margin = -3819 % (FCF TTM -18.14b / Revenue TTM 474.9m)
Net Margin = 1667 % (Net Income TTM 7.92b / Revenue TTM 474.9m)
Gross Margin = 70.12% ((Revenue TTM 474.9m - Cost of Revenue TTM 141.9m) / Revenue TTM)
Gross Margin QoQ = 70.46% (prev 68.77%)
Tobins Q-Ratio = 0.80 (Enterprise Value 58.64b / Total Assets 73.62b)
Interest Expense / Debt = 1.08% (Interest Expense 88.9m / Debt 8.22b)
Taxrate = 28.06% (1.09b / 3.87b)
NOPAT = 7.95b (EBIT 11.05b * (1 - 28.06%))
Current Ratio = 0.66 (Total Current Assets 214.0m / Total Current Liabilities 324.1m)
Debt / Equity = 0.14 (Debt 8.22b / totalStockholderEquity, last quarter 58.12b)
Debt / EBITDA = 0.74 (Net Debt 8.17b / EBITDA 11.05b)
Debt / FCF = -0.45 (negative FCF - burning cash) (Net Debt 8.17b / FCF TTM -18.14b)
Total Stockholder Equity = 40.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.75% (Net Income 7.92b / Total Assets 73.62b)
RoE = 19.76% (Net Income TTM 7.92b / Total Stockholder Equity 40.06b)
RoCE = 22.91% (EBIT 11.05b / Capital Employed (Equity 40.06b + L.T.Debt 8.17b))
RoIC = 17.48% (NOPAT 7.95b / Invested Capital 45.48b)
WACC = 12.23% (E(50.47b)/V(58.69b) * Re(14.09%) + D(8.22b)/V(58.69b) * Rd(1.08%) * (1-Tc(0.28)))
Discount Rate = 14.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 28.62%
Fair Price DCF = unknown (Cash Flow -18.14b)
EPS Correlation: 24.05 | EPS CAGR: 13.02% | SUE: -2.51 | # QB: 0
Revenue Correlation: -49.41 | Revenue CAGR: -1.17% | SUE: 2.69 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.39 | Chg30d=+1.465 | Revisions Net=+0 | Analysts=4
EPS next Year (2026-12-31): EPS=32.73 | Chg30d=+21.937 | Revisions Net=+0 | Growth EPS=-33.4% | Growth Revenue=+2.4%
Additional Sources for MSTR Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle